Initial Multicenter Experience With Double Nucleoside Therapy for Human Immunodeficiency Virus Infection During Pregnancy
Objective: To study maternal and neonatal effects of combination nucleoside analog therapy administered to human immunodeficiency virus (HIV)-infected pregnant women for maternal indications.
Saved in:
Main Authors: | N. S. Silverman (Author), D. H. Watts (Author), J. Hitti (Author), D. M. Money (Author), E. Livingston (Author), J. Axelrod (Author), J. M. Ernest (Author), D. Robbins (Author), M. M. DiVito (Author) |
---|---|
Format: | Book |
Published: |
Hindawi Limited,
1998-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Nucleoside Modifications
Published: (2017) -
Vitamin E Phosphate Nucleoside Prodrugs: A Platform for Intracellular Delivery of Monophosphorylated Nucleosides
by: Richard Daifuku, et al.
Published: (2018) -
Emerging Roles of Nucleoside Transporters
by: Marçal Pastor-Anglada, et al.
Published: (2018) -
Design and synthesis of potential ribonucleotide reductase enzyme (RNR) inhibitors as antileukemic and/or antiviral 2'-deoxymethylene nucleosides
by: Khairia M. Youssef, et al.
Published: (2015) -
Nucleosides present on phlebotomine saliva induce immunossuppression and promote the infection establishment.
by: Vanessa Carregaro, et al.
Published: (2015)